Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayer

Jingwei Xie, Chenlu Lei, Yong Hu, Gary Kaizhong Gay, Nazrul Hadi Bin Jamali, Chi Hwa Wang

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Paclitaxel appears to be a potential substrate of the multidrug resistance protein p-glycoprotein, thus preventing itself from entry into the brain and penetrating blood-brain barrier poorly. In this study, the main objective was to design paclitaxel formulation using PLGA-based nanoparticles with different additives and surface coatings to facilitate the paclitaxel transport through MDCK cell monolayer. PLGA-based nanoparticles of around 200 nm without and with additives and surface coatings were developed by direct dialysis. The transendothelial electrical resistance (TEER) variation of MDCK cell monolayer on the cell inserts imposed by paclitaxel-loaded nanoparticles with and without additives was investigated. (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) (MTT) assay was used to quantify the cell viability of C6 glioma cells after administration of formulations on the topical side. Investigations showed that particles with additives were able to enhance cellular uptake more than surface-coated particles. TEER values dropped upon the introduction of paclitaxel-loaded PLGA nanoparticles to the cell inserts. After incubation for 24 h, the cell viability of C6 glioma cells in the wells treated with nanoparticles was lower than that of the control wells without particles. Taken together, PLGA nanoparticles with vitamin E TPGS and polysorbate 80 as additives were successfully obtained as paclitaxel formulations, demonstrating great potential for the delivery of paclitaxel through MDCK cell monolayer in vitro.

Original languageEnglish (US)
Pages (from-to)2331-2340
Number of pages10
JournalCurrent Pharmaceutical Design
Volume16
Issue number21
DOIs
StatePublished - 2010
Externally publishedYes

Keywords

  • Blood-brain barrier
  • Cancer chemotherapy
  • Coating
  • MDCK
  • Nanoparticles

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayer'. Together they form a unique fingerprint.

  • Cite this